• Crizotinib Hydrochloride in Advanced ALK Kinase Inhibitor As

  2026-04-25

  Crizotinib hydrochloride empowers researchers to dissect ALK, c-Met, and ROS1 signaling in complex assembloid models that mimic human tumor microenvironments. This guide details optimized protocols, troubleshooting, and the translation of patient-derived cancer assembloid innovations into actionable workflows for oncogenic kinase pathway research.

• Ionomycin Calcium Salt: Advanced Dissection of Ca2+ Signalin

  2026-04-24

  Explore the multifaceted role of Ionomycin calcium salt as a calcium ionophore for advanced research into calcium signaling, apoptosis, and cancer metastasis. This article delivers a deeper mechanistic perspective and practical assay guidance, standing apart from existing content.

• Comparative Antibacterial Profiling of Cefoperazone and β-La

  2026-04-24

  This article reviews a pivotal study comparing the antibacterial activities of N-formimidoyl thienamycin (MK0787) with advanced β-lactam antibiotics, including cefoperazone, against multidrug-resistant gram-negative and gram-positive clinical isolates. The findings inform assay design, resistance studies, and strategic antibiotic selection in translational microbiology.

• Deletion of Chicken MHC Class I Gene BF1 via Direct Repeats

  2026-04-23

  This study uncovers the complete deletion of the minor class I gene BF1 in the B14 and typical B15 chicken MHC haplotypes, linked to recombination between short imperfect direct repeats. The findings have important implications for avian immunogenetics and provide a model for studying gene loss via microhomology-mediated events.

• Sensitive Yeast Screening Accelerates Discovery of mTOR Inhi

  2026-04-23

  This study introduces a drug-sensitized yeast platform that enables highly sensitive and selective identification of mTOR inhibitors, surpassing detection limits of traditional assays. The system robustly distinguishes true TOR pathway inhibitors from compounds that act via unrelated mechanisms, offering researchers a rapid and cost-effective tool for advancing aging and metabolic disorder investigations.

• Dual Enzyme-Responsive Zwitterionic Peptides for Cancer Sele

  2026-04-22

  This study introduces a peptide amphiphile that employs dual enzyme responsiveness and zwitterionic self-assembly to enable highly selective cancer cell targeting. The approach leverages sequential enzymatic disassembly and assembly within lysosomes, resulting in selective cytotoxicity toward cancer cells while sparing normal tissues, presenting a promising advance in precision peptide-based cancer therapeutics.

• Mutational Landscape of Myeloma Cell Lines: Insights for Dru

  2026-04-22

  This study provides the first comprehensive exome-wide characterization of human multiple myeloma cell lines (HMCLs), identifying 236 recurrently mutated protein-coding genes and key altered pathways implicated in tumor progression and drug resistance. The findings establish an essential genomic resource for selecting relevant in vitro models and inform mechanistic studies on therapeutic response and resistance.

• GANT61 as a GLI Inhibitor: Translational Leverage in Tumor I

  2026-04-21

  Explore how GANT61, a potent GLI inhibitor, enables precision targeting of GLI1/2 transcription factors to dissect tumor immune evasion and resistance. This article uniquely connects mechanistic insights and practical assay guidance for advanced cancer research.

• Workflow Guide: Prestained Protein Marker (Triple color, EDT

  2026-04-21

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) addresses the need for accurate, visible molecular weight standards in SDS-PAGE and Western blot workflows, especially where EDTA-sensitive applications or fluorescent imaging are required. It is not intended for applications requiring quantification of protein concentration or for use outside the 10–250 kDa range.

• MPC-Driven Lactate and Histone Lactylation in Tumor Immunity

  2026-04-20

  Zhang et al. (2025) reveal that mitochondrial pyruvate carrier (MPC) downregulation in colorectal cancer promotes lactate accumulation, driving histone lactylation in dendritic cells and impairing anti-tumor immune responses. Their mechanistic findings highlight lactate metabolism's epigenetic control of immune surveillance and suggest metabolic interventions to enhance immunotherapy efficacy.

• GSDMC Identified as a Therapeutic Target in Pancreatic Adeno

  2026-04-20

  Yan et al. developed a prognostic model for pancreatic adenocarcinoma based on pyroptosis-related genes, highlighting GSDMC as a novel therapeutic target. Their integrative analysis also identified small molecules, including PD 173074, as candidates for modulating tumor progression and prognosis.

• Mutational Profiling in Myeloma Cell Lines: Implications for

  2026-04-19

  This study provides the first comprehensive exome-wide analysis of 30 human multiple myeloma cell lines, uncovering key mutated pathways and potential genetic drivers linked to tumor progression and drug resistance. These insights offer a valuable foundation for selecting experimental models and designing targeted therapeutic research in multiple myeloma.

• TAK-242 (Resatorvid): Translating TLR4 Inhibition to Neuroim

  2026-04-18

  Explore how TAK-242 (Resatorvid) enables advanced, quantitative TLR4 pathway modulation in neuroinflammation research. This article uniquely focuses on assay optimization and preclinical decision-making powered by recent mechanistic breakthroughs.

• Valemetostat (DS-3201): Clinical Translation in Lymphoma The

  2026-04-17

  Explore the clinical impact of Valemetostat, a dual EZH1/EZH2 inhibitor, in relapsed or refractory lymphoma. This in-depth review uniquely connects phase 1 trial insights to practical assay selection and translational research decisions.

• Polyethylenimine Linear (PEI MW 40,000): Advanced DNA Transf

  2026-04-16

  Polyethylenimine Linear (PEI MW 40,000) excels as a versatile DNA transfection reagent, delivering high efficiency from microplate to bioreactor scale. This article reveals protocol upgrades, troubleshooting strategies, and real-world applications bridging cutting-edge epigenetic research with streamlined recombinant protein workflows.

401 records 17/27 page Previous Next First page 上5页 1617181920 下5页 Last page